Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
Saved in:
| Title: | Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations. |
|---|---|
| Authors: | Mayhew D; Computational Biology, Target Sciences, GSK R&D, King of Prussia, Pennsylvania, USA., Devos N; GSK Vaccines, Rixensart, Belgium., Lambert C; GSK Vaccines, Rixensart, Belgium., Brown JR; Computational Biology, Target Sciences, GSK R&D, King of Prussia, Pennsylvania, USA., Clarke SC; Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.; Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, UK., Kim VL; Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, UK., Magid-Slav M; Computational Biology, Target Sciences, GSK R&D, King of Prussia, Pennsylvania, USA., Miller BE; Respiratory Therapy Area Unit, GSK R&D, King of Prussia, Pennsylvania, USA., Ostridge KK; Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, UK., Patel R; Target and Pathway Validation, Target Sciences, GSK R&D, King of Prussia, Pennsylvania, USA., Sathe G; Target and Pathway Validation, Target Sciences, GSK R&D, King of Prussia, Pennsylvania, USA., Simola DF; Computational Biology, Target Sciences, GSK R&D, King of Prussia, Pennsylvania, USA., Staples KJ; Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.; Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, UK.; Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK., Sung R; Respiratory Therapy Area Unit, GSK R&D, King of Prussia, Pennsylvania, USA., Tal-Singer R; Respiratory Therapy Area Unit, GSK R&D, King of Prussia, Pennsylvania, USA., Tuck AC; Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK., Van Horn S; Target and Pathway Validation, Target Sciences, GSK R&D, King of Prussia, Pennsylvania, USA., Weynants V; GSK Vaccines, Rixensart, Belgium., Williams NP; Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, UK., Devaster JM; GSK Vaccines, Rixensart, Belgium., Wilkinson TMA; Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.; Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, UK.; Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK. |
| Corporate Authors: | AERIS Study Group |
| Source: | Thorax [Thorax] 2018 May; Vol. 73 (5), pp. 422-430. Date of Electronic Publication: 2018 Jan 31. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: British Medical Assn Country of Publication: England NLM ID: 0417353 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3296 (Electronic) Linking ISSN: 00406376 NLM ISO Abbreviation: Thorax Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 29386298 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mayhew+D%22">Mayhew D</searchLink>; Computational Biology, Target Sciences, GSK R&D, King of Prussia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Devos+N%22">Devos N</searchLink>; GSK Vaccines, Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22Lambert+C%22">Lambert C</searchLink>; GSK Vaccines, Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22Brown+JR%22">Brown JR</searchLink>; Computational Biology, Target Sciences, GSK R&D, King of Prussia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Clarke+SC%22">Clarke SC</searchLink>; Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.; Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Kim+VL%22">Kim VL</searchLink>; Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Magid-Slav+M%22">Magid-Slav M</searchLink>; Computational Biology, Target Sciences, GSK R&D, King of Prussia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Miller+BE%22">Miller BE</searchLink>; Respiratory Therapy Area Unit, GSK R&D, King of Prussia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Ostridge+KK%22">Ostridge KK</searchLink>; Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Patel+R%22">Patel R</searchLink>; Target and Pathway Validation, Target Sciences, GSK R&D, King of Prussia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Sathe+G%22">Sathe G</searchLink>; Target and Pathway Validation, Target Sciences, GSK R&D, King of Prussia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Simola+DF%22">Simola DF</searchLink>; Computational Biology, Target Sciences, GSK R&D, King of Prussia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Staples+KJ%22">Staples KJ</searchLink>; Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.; Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, UK.; Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Sung+R%22">Sung R</searchLink>; Respiratory Therapy Area Unit, GSK R&D, King of Prussia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Tal-Singer+R%22">Tal-Singer R</searchLink>; Respiratory Therapy Area Unit, GSK R&D, King of Prussia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Tuck+AC%22">Tuck AC</searchLink>; Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Van+Horn+S%22">Van Horn S</searchLink>; Target and Pathway Validation, Target Sciences, GSK R&D, King of Prussia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Weynants+V%22">Weynants V</searchLink>; GSK Vaccines, Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22Williams+NP%22">Williams NP</searchLink>; Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Devaster+JM%22">Devaster JM</searchLink>; GSK Vaccines, Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22Wilkinson+TMA%22">Wilkinson TMA</searchLink>; Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.; Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, UK.; Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22AERIS+Study+Group%22">AERIS Study Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220417353%22">Thorax</searchLink> [Thorax] 2018 May; Vol. 73 (5), pp. 422-430. <i>Date of Electronic Publication: </i>2018 Jan 31. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22British+Medical+Assn%22">British Medical Assn </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0417353 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1468-3296 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200406376%22">00406376 </searchLink><i>NLM ISO Abbreviation: </i>Thorax <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29386298 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/thoraxjnl-2017-210408 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 422 Titles: – TitleFull: Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mayhew D – PersonEntity: Name: NameFull: Devos N – PersonEntity: Name: NameFull: Lambert C – PersonEntity: Name: NameFull: Brown JR – PersonEntity: Name: NameFull: Clarke SC – PersonEntity: Name: NameFull: Kim VL – PersonEntity: Name: NameFull: Magid-Slav M – PersonEntity: Name: NameFull: Miller BE – PersonEntity: Name: NameFull: Ostridge KK – PersonEntity: Name: NameFull: Patel R – PersonEntity: Name: NameFull: Sathe G – PersonEntity: Name: NameFull: Simola DF – PersonEntity: Name: NameFull: Staples KJ – PersonEntity: Name: NameFull: Sung R – PersonEntity: Name: NameFull: Tal-Singer R – PersonEntity: Name: NameFull: Tuck AC – PersonEntity: Name: NameFull: Van Horn S – PersonEntity: Name: NameFull: Weynants V – PersonEntity: Name: NameFull: Williams NP – PersonEntity: Name: NameFull: Devaster JM – PersonEntity: Name: NameFull: Wilkinson TMA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2018 May Type: published Y: 2018 Identifiers: – Type: issn-electronic Value: 1468-3296 Numbering: – Type: volume Value: 73 – Type: issue Value: 5 Titles: – TitleFull: Thorax Type: main |
| ResultId | 1 |